Category: Disease Discoveries
-
ALS Drug Grant to Spur Drug Discovery at Northwestern
Two Northwestern University scientists have received a $3.1 million grant from the National Institute on Aging to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).
-
Sesame Allergy is More Common Than Previously Recognized
Sesame allergy affects more than 1 million children and adults in the U.S., more than previously known, according to a new Northwestern Medicine study.
-
New Target for Slowing Breast Cancer’s Spread to Brain
Northwestern Medicine scientists have identified a protein that helps reprogram HER2-positive breast cancer cells to survive in the brain, according to a recent study.
-
New Approach Shows Promise in Treating Parkinson’s Symptoms
Northwestern Medicine scientists have rescued movement in a mouse model of Parkinson’s disease by restoring the intrinsic discharge of nerve cells within the subthalamic nucleus.
-
Procedure Proves Effective in Treating Rare Swallowing Disorder
A procedure called POEM significantly improved treatment outcomes among patients with achalasia — a rare swallowing disorder — compared with a standard therapy, according to a clinical trial published in JAMA.
-
New Developments in Quest for Huntington’s Disease Treatments
A molecule drastically reduced toxic proteins in human neuron cells with Huntington’s disease, representing a potential therapy for the deadly degenerative disease, according to a new study.
-
Exploring the Molecular Mechanisms of Ion Channels and Kidney Disease
Northwestern Medicine scientists have discovered the molecular mechanism by which voltage-dependent gates regulate the flow of ions in a unique sub-class of proteins called polycystic receptor potential channels.
-
Targeting a Weak Link in Pediatric Brain Cancer
A new study has found that a particularly deadly form of pediatric brain tumor may have a weakness that could inspire future treatments.
-
New Insights Into Role of RNA Methylation in Fragile X Syndrome
Northwestern Medicine scientists have discovered that the protein FMRP — the loss of which leads to Fragile X syndrome — is a novel reader of RNA methylation.
-
Pancreatic Cancer Drug, High-Fat Diet Linked to Liver Disease Risk
An emerging class of cancer drugs has shown promise in treating pancreatic cancer, but the drugs may cause severe liver damage when combined with high-fat diets, according to study published in PNAS.
